Coronavirus Live
Covid-19 live timeline
Here's the timeline of how the Coronavirus outbreak evolved from Wuhan city in China and is spreading across the world...
Focus:
-
![How the University of Oxford is leading the Covid-19 fight on multiple fronts]()
How the University of Oxford is leading the Covid-19 fight on multiple fronts
-
![Firms may find it ‘difficult’ to co-market combined Covid-19 drugs, says analyst]()
Firms may find it ‘difficult’ to co-market combined Covid-19 drugs, says analyst
-
![Majority of Covid-19 clinical trials showing ‘encouraging’ signs, says analyst]()
Majority of Covid-19 clinical trials showing ‘encouraging’ signs, says analyst
-
![How BerGenBio became a frontrunner in UK hunt for Covid-19 treatment]()
How BerGenBio became a frontrunner in UK hunt for Covid-19 treatment
-
![Pfizer: How one of the world’s largest pharma firms is tackling Covid-19]()
Pfizer: How one of the world’s largest pharma firms is tackling Covid-19
-
![GSK-Sanofi alliance: are pharma partnerships key to ending Covid-19?]()
GSK-Sanofi alliance: are pharma partnerships key to ending Covid-19?
Coronavirus Live
- Economic Update: Exports to China could fall by 46% – 40 million unemployed in US – international community needs to revisit finance goals
- UK position in global clinical trials sector could receive boost after Covid-19
- International Update: Global Covid-19 infections exceed 5.8 million – more than 100,000 covid deaths in US
Expert commentary & analysis from GlobalData
CVMD clinical trial disruptions due to Covid-19; studies slow to resume investigation of diabetes drugs intensifies
Novo Nordisk’s semaglutide demonstrates superior weight loss versus placebo in STEP 4 trial
Clinical trials disrupted due to Covid-19 slowly resume
Roche’s Tecentriq gains first-line approval in NSCLC but Merck’s Keytruda dominates the space
Most Read
Company releases
Antioxplan
Antioxplan contains per capsule
OnAsset Intelligence Accomplishes Significant Breakthrough In The Development Of NexBox
2020 Forthcoming Events
Below are the forthcoming shows that will exhibit Malvern’s pharmaceutical solutions.
ACTide Against Covid-19 from Nubilaria
The Importance of Working in an Electrospinning Chamber
When working with high voltages, safety is the number one priority. With the Linari electrospinning...
Company whitepapers
Defeating the Spread of Covid-19 with Laboratory Equipment from IKA
Ika-WerkeData Logging and Real-Time Piece Visibility for Life Sciences and Pharmaceutical Products in the Supply Chain
OnAsset IntelligenceIoT Tracking and Monitoring
OnAsset IntelligenceTroubleshooting and Common Issues
Linari NanoTechBattery Research and Quality Control Solutions
Malvern PanalyticalElectrospinning for Beginners
Linari NanoTechPartnership presentation
SOM BiotechCompany A-Z
Clinical Trials
LabCorp’s Covance expands trial technology with Medable
US-based life sciences firm LabCorp has announced that Covance, its drug development business, is bolstering its technology ecosystem to speed up the adoption of decentralised...
AstraZeneca’s Tagrisso improves survival in lung cancer patients
UK researchers study anti-inflammatory drug camostat for Covid-19
PureTech to assess LYT-100 for Covid-19 respiratory complications
Cambridge Cognition secures more virtual clinical trials during Covid-19 crisis
Drug Development
AstraZeneca’s Tagrisso improves survival in lung cancer patients
AstraZeneca has reported positive results from the Phase III ADAURA clinical trial of Tagrisso (osimertinib) in patients with early-stage epidermal growth factor receptor-mutated (EGFRm) non-small...
UK researchers study anti-inflammatory drug camostat for Covid-19
PureTech to assess LYT-100 for Covid-19 respiratory complications
Atriva Therapeutics to conduct Phase II Covid-19 trial
Aerpio and Quantum Leap to study razuprotafib for ARDS in Covid-19
Your recommended content
Why we believe workplace health and wellness is important
Your recommended content
Reinventing construction: Innovating the delivery of construction projects
Download a free 10 page preview of our Mergers & Acquisitions in TMT – Thematic Research 2019 Report
Go Top